Jas I haven’t posted for a while - the board has taken on a very depressed short term view- ok we all should have sold in the 20’s I just bought more shares in Amarin Ok - so the SP under 4 - what does that tell us ?? It tell us nothing about the real value or potential value of this company if you take a long view - Things have to change in the way the business has been operated-communication communication communication Things will now change with the new regime - there will be a revitalisation- Karim has to show he is a ballsy dynamic new CEO- and Let us not forget The patent litigation war is far from over - I am a lawyer - appalled by the Du case —A travesty of justice but an inept failure by the company to protect its patents - they sat on their laurels and got stuffed by the deviousness of generic litigation - but The patent loss has so far only hit a tops reduction of less than 15 per cent The Europe/ China /Row market is one of immense potential The drug is likely to have huge impact in other areas - covid/alz..et al The co may yet attract a buyer
Will this share be trading at 4 in five years time ?? I predicted 22 by end of year -around the average view in rafs poll - Ok - the average and I are going to be wrong - we seemed on our way at 9 after Europe approval
But will we get there in the years ahead - 2 or 3 years maybe 5 I will be happy to get to 22 in 5 years time that will be a 5 fold increase in my assets
Jas I haven’t posted for a while - the board has taken on a very depressed short term view- ok we all should have sold in the 20’s I just bought more shares in Amarin Ok - so the SP under 4 - what does that tell us ?? It tell us nothing about the real value or potential value of this company if you take a long view - Things have to change in the way the business has been operated-communication communication communication Things will now change with the new regime - there will be a revitalisation- Karim has to show he is a ballsy dynamic new CEO- and Let us not forget The patent litigation war is far from over - I am a lawyer - appalled by the Du case —A travesty of justice but an inept failure by the company to protect its patents - they sat on their laurels and got stuffed by the deviousness of generic litigation - but The patent loss has so far only hit a tops reduction of less than 15 per cent The Europe/ China /Row market is one of immense potential The drug is likely to have huge impact in other areas - covid/alz..et al The co may yet attract a buyer
Will this share be trading at 4 in five years time ?? I predicted 22 by end of year -around the average view in rafs poll - Ok - the average and I are going to be wrong - we seemed on our way at 9 after Europe approval
But will we get there in the years ahead - 2 or 3 years maybe 5 I will be happy to get to 22 in 5 years time that will be a 5 fold increase in my assets
News 
Market Data 
Discover 
